XML 42 R21.htm IDEA: XBRL DOCUMENT v3.22.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)
3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Components of selected captions in the consolidated condensed balance sheets consisted of the following:
March 31, 2022December 31, 2021
Inventories
Raw materials$137.4 $132.8 
Work in process150.6 164.3 
Finished products442.6 429.6 
$730.6 $726.7 
Schedule of Accounts Payable and Accrued Liabilities
March 31, 2022December 31, 2021
Accrued and other liabilities 
Employee compensation and withholdings$221.7 $319.7 
Taxes payable93.1 30.6 
Property, payroll, and other taxes69.2 68.9 
Research and development accruals56.5 58.2 
Accrued rebates78.4 77.0 
Fair value of derivatives3.8 3.9 
Accrued marketing expenses16.8 20.1 
Legal and insurance (a)
78.3 79.1 
Accrued relocation costs27.6 26.2 
Accrued professional services14.2 11.9 
Accrued realignment reserves19.4 19.1 
Other accrued liabilities88.2 87.6 
$767.2 $802.3 
_______________________________________
(a)     On July 12, 2020, the Company reached an agreement with Abbott Laboratories and its direct and indirect subsidiaries to, among other things, settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. As of March 31, 2022, $50.0 million was accrued in "Accrued and other liabilities" and $181.3 million was accrued in "Litigation settlement accrual" on the consolidated condensed balance sheet.
Schedule of Cash Flow, Supplemental Disclosures
Supplemental Cash Flow Information
(in millions)
Three Months Ended
March 31,
20222021
Cash paid during the year for:
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
$7.6 $7.7 
Non-cash investing and financing transactions:  
Right-of-use assets obtained in exchange for new lease liabilities$6.4 $3.5 
Capital expenditures accruals$23.8 $36.4 
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents, and Restricted Cash
(in millions)
March 31, 2022December 31, 2021
Cash and cash equivalents$1,030.9 $862.8 
Restricted cash included in other current assets1.3 1.5 
Restricted cash included in other assets3.1 3.1 
Total cash, cash equivalents, and restricted cash$1,035.3 $867.4 
Schedule of Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
(in millions)
March 31, 2022December 31, 2021
Cash and cash equivalents$1,030.9 $862.8 
Restricted cash included in other current assets1.3 1.5 
Restricted cash included in other assets3.1 3.1 
Total cash, cash equivalents, and restricted cash$1,035.3 $867.4